Image map spacer graphicUW Medicine Home PageUW School of Medicine Home PageUW Physicians Neighborhood Clinics Home PageUW Medical Center Home PageHarborview Medical Center Home Page

Take me to:
UW Medicine Home
Radiation Oncology Home
Research

Medical Physics

Clinical Program
Academic
Milestones
Articles and
Proceedings
Abstracts and Talks
Education and Training
UWMC Cancer Center
Seattle Cancer Care Alliance

Contact Radiation Oncology:
E-mail us
Tel: 206-598-4100
Send mail to:
Radiation Oncology
Dept.
UW Box 356043
Seattle, WA 98195
page header graphic

Medical Physics Group

Paul Cho, Ph.D.

598-4754
psncho@u.washington.edu
Rob Emery 598-6792 duma@u.washington.edu
Robert Giansiracusa, M.S.

598-6259
bobgian@u.washington.edu
Ira Kalet, Ph.D.

598-4107
ikalet@u.washington.edu
Homayon Parsai, Ph.D.

598-4143
hparsai@u.washington.edu
Mark Phillips, Ph.D.

598-6219
markp@u.washington.edu
Alina Popescu, Ph.D.

598-4231
alina@u.washington.edu
Dave Reid 598-4536 dreid@u.washington.edu
Ruedi Risler, Dr. Sci. Nat.

598-4136
risler@u.washington.edu
Mark Wagner, B.S.

598-0302
markwag@u.washington.edu
Lori Young, Ph.D.

598-4736
layoung@u.washington.edu
Peter Wootton, B.Sc. Professor Emeritus

Clinical Physics

Mark Phillips, Ph.D.
Lori Young, Ph.D.

Homayon Parsai, Ph.D.
Alina Popescu, Ph.D.

The Clinical Physics group has three missions that are closely related. The first is to provide physics support for the clinical procedures in the department. The second is to develop, test, and implement new technologies in radiation therapy. The third is to conduct basic medical physics research applicable to radiation oncology and to translate that research into clinically useful tools.

Currently we provide clinical physics services to the Department of Radiation Oncology at UWMC, to Radiation Oncology at the Seattle Cancer Care Alliance, and to the Gamma Knife at Harborview Hospital. The procedures for which we provide services include external beam therapy with x-rays, electrons and neutrons, brachytherapy including HDR and prostate seed implants, radiosurgery, stereotactic radiotherapy using stereocameras, IMRT, total body irradiations, total skin electron irradiation, eye plaques, and intravascular brachytherapy.


New technology development:

The integration of new technology is an important component of our work. Our accomplishments range from small, short-term projects to large, on-going projects linked with our research efforts. One example was the beta-testing and extension of the stereocamera system so that it could be integrated into our treatment planning system for 3D conformal therapy and IMRT as well as being used for stereotactic radiotherapy. An example of the larger projects is our in-house treatment planning systems, which led the way in 3D conformal therapy and is a source of on-going research and development.


Research:

The medical physics group engages in a variety of research activities. The current research projects include:

  • Algorithms for automatic generation of clinical target volumes in head and neck cancer
    (Ira Kalet, Mary Austin-Seymour)
  • Intraoperative Dose Optimization For Prostate Brachytherapy
    (Paul Cho)

  • Advanced Inverse Planning Algorithm For IMRT
    (Paul Cho)
  • Image Guided Therapy
    (Mark Phillips, Paul Cho, Juergen Meyer)
  • Improvements in Radiation Therapy Plan Optimization
    (Mark Phillips, Juergen Meyer, Ira Kalet)
  • Improved Seeds for Permanent Seed Implants for Prostate Cancer
    (Mark Phillips)
The research activities of the faculty members include collaborations with Biomedical and Health Informatics, Otolaryngology, Computer Scienceand Engineering, Electrical Engineering, Nuclear Medicine/PET Group, and the VA-Puget Sound.
  • Algorithms for automatic generation of clinical target volumes in head and neck cancer
    (Ira Kalet, Mary Austin-Seymour)
    The success of radiation therapy depends critically on accurately delineating the target volume, which is the region of known or suspected disease in a patient. Methods that can compute a contour set defining a target volume on a set of patient images will contribute greatly to the success of radiation therapy and dramatically reduce the workload of radiation oncologists, who currently draw the target by hand on the images using simple computer drawing tools. The most challenging part of this process is to estimate where there is microscopic spread of disease. We are developing methods for automatically selecting and adapting standardized regions of tumor spread based on the location of lymph nodes in a standard or reference case, together with image registration techniques. The best available image registration techniques (deformable transformations computed using ``mutual information'' optimization) appear promising but will need to be supplemented by anatomic knowledge-based methods to achieve a clinically acceptable match. This project also involves collaboration from Mark Whipple, Otolaryngology/Head and Neck Surgery, Linda Shapiro, Computer Science and Engineering/Electrical Engineering, and Chia-Chi Teng, Electrical Engineering graduate student.


  • Intraoperative Dose Optimization For Prostate Brachytherapy
    (Paul Cho)

    While brachythearpy has proven to be an effective treatment modality for early-stage prostate cancer, local failure and recurrence do occur. Based on the post-implant analysis correlating the PSA level and the principal dosimetric parameters, it is evident that the probability of cure increases with improved dose distribution. The primary objective of the proposed research is to develop an intraoperative method to measure and modify dose distribution for optimal outcome. Specific aims include: (1) automated detection and localization of seeds from multiple fluoroscopy projections, (2) semi-automated segmentation of prostate volume from ultrasound, (3) automated registration of seeds and prostate volume, (4) development of dose modification supervisor, and (5) clinical evaluation of the target system. The project is funded by NIH/NCI and DoD.


  • Advanced Inverse Planning Algorithm For IMRT
    (Paul Cho)
    It has been shown that the inverse problem in IMRT is severly ill-conditioned. The mathematical limitation inherent in inverse planning algorithms has not yet been quantified and properly regulated. The present research exploits the power of singular value decomposition to characterize and regulate the dose matrices for optimal convergence to a feasible solution. Tikhonov method combined with convex projection is being investigated.


  • Image Guided Therapy
    (Mark Phillips, Paul Cho, Juergen Meyer)
    Advances in imaging physiological processes, e.g. hypoxia, are an important development in targetting tissues for radiation therapy as well as assessing response to treatment. A collaboration with the Nuclear Medicine/PET group at UWMC is working to develop and apply deformable image registration for two separate clinical studies. The first is to use PET-FDG to reduce the size of target volumes in head and neck cancer, and thus reduce morbidity. The other is to use PET-FMISO to image hypoxia in head and neck tumors and to use the information to design IMRT treatments and to assess the response of the hypoxic regions to radiation therapy. This work is being performed in conjunction with the Nuclear Medicine Department (Paul Kinahan, Joseph Rajendran) and VA-Puget Sound (Eric Ford, David Schwartz).


  • Improvements in Radiation Therapy Plan Optimization
    (Mark Phillips, Juergen Meyer, Ira Kalet)
    Treatment planning optimization has recently received much attention due to the advent of inverse planning techniques for IMRT. As useful as these algorithms are, they all have difficulty in handling the predominant situations in radiation therapy. These problems include decisions based on models formulated with incomplete data, incomplete and qualitative presriptions, and mutually contradictory constraints/objectives. Our project is aimed at using belief nets (also known as Bayes' nets) to provide better methods at guiding the optimization process and choosing the most clinically appropriate solution.


  • Improved Seeds for Permanent Seed Implants for Prostate Cancer
    (Mark Phillips)
    Classic radiation biology has always categorized tumor response as having a high alpha/beta ratio, similar to that of acutely responding tumors. This has resulted in treatment strategies that make use of prolonged fractionation schedules in order to achieve the most separation between the tumor response and dose-limiting late responding tumors. Recent clinical results have indicated that for prostate tumors the alpha/beta ratio is probably less than 3, similar to late responding tissues. In addition, recently published data indicate that repair is much slower than previous thought. In a project done in collaboration with IsoRay, Inc., a company designing and developing novel isotope-seed combinations, I am investigating the potential advantages that would result from a shorter half-life isotope for permanent seed implants in light of the profound changes in the radiobiological modelling of prostate cancer.



Copyright © 2004 University of Washington